Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 200 Total
VVPR - VivoPower International PLC - Stock Price Chart
TickerVVPR [NASD]
CompanyVivoPower International PLC
CountryUnited Kingdom
IndustrySolar
Market Cap4.55MEPS (ttm)-3.19
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y13.82%
P/S0.37EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own53.89%Inst Own1.15%
Insider Trans0.00%Inst Trans-
Short Float3.50%Earnings-
Analyst Recom1.00Target Price50.00
Avg Volume2.89M52W Range1.02 - 9.90
VivoPower International Plc is a sustainable energy solutions company, which engages in the customers with turnkey decarbonization solutions that enable them to achieve net zero carbon status. It operates through the following segments: Critical Power Services, Electric Vehicles, Sustainable Energy Solutions, Solar Development, and Corporate Office. The Critical Power Services segment focuses on the design, supply, installation, and maintenance of critical power, control and distribution systems, including for solar farms. The Electric Vehicles segment delivers electric vehicles for mining and other rugged industrial customers. The Sustainable Energy Solutions segment refers to the design, evaluation, sale, and implementation of renewable energy infrastructure to customers both on a standalone basis and in support of Tembo Electric Vehicles. The Solar Development segment represented by caret comprises of 12 solar projects in the US. The Corporate Office segment includes the company's corporate functions, which refers to the costs to maintain Nasdaq listing, comply with applicable SEC reporting requirements, and related investor relations. The company was founded by Tser Fah Chin on February 1, 2016 and is headquartered in London, the United Kingdom.
SLS - SELLAS Life Sciences Group Inc - Stock Price Chart
TickerSLS [NASD]
CompanySELLAS Life Sciences Group Inc
CountryUSA
IndustryBiotechnology
Market Cap61.21MEPS (ttm)-1.11
P/E-EPS this Y45.77%
Forward P/E-EPS next Y17.43%
PEG-EPS past 5Y61.44%
P/S-EPS next 5Y-
P/B6.16EPS Q/Q54.70%
Dividend-Sales Q/Q-
Insider Own0.27%Inst Own13.36%
Insider Trans0.00%Inst Trans-11.61%
Short Float13.27%EarningsMay 14/a
Analyst Recom1.00Target Price5.83
Avg Volume1.46M52W Range0.50 - 1.91
Jun-17-24 09:45AM Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase (GlobeNewswire) -16.67%
09:05AM SELLAS Life Sciences Announces Positive Recommendation from the Independent Data Monitoring Committee of the Phase 3 REGAL Trial in Acute Myeloid Leukemia (GlobeNewswire)
Jun-10-24 08:40AM SELLAS Announces Completion of Enrollment and Initial Positive Data in Phase 2a Trial of SLS009 in r/r AML (GlobeNewswire)
May-14-24 10:54PM SLS Stock Earnings: SELLAS Life Sciences Gr Misses EPS for Q1 2024 (InvestorPlace) +7.30%
04:05PM SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-01-24 08:35AM SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level (GlobeNewswire)
Apr-29-24 08:45AM SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study (GlobeNewswire) -17.12%
Mar-28-24 10:54PM SLS Stock Earnings: SELLAS Life Sciences Gr Misses EPS for Q4 2023 (InvestorPlace) +5.94%
04:05PM SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
07:00AM GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA (zanubrutinib) Treating Diffuse Large B Cell Lymphoma (PR Newswire)
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
CANF - Can-Fite Biopharma Ltd ADR - Stock Price Chart
TickerCANF [AMEX]
CompanyCan-Fite Biopharma Ltd ADR
CountryIsrael
IndustryBiotechnology
Market Cap13.62MEPS (ttm)-1.86
P/E-EPS this Y51.05%
Forward P/E-EPS next Y24.49%
PEG-EPS past 5Y48.75%
P/S18.41EPS next 5Y-
P/B1.98EPS Q/Q67.30%
Dividend-Sales Q/Q-21.32%
Insider Own-Inst Own9.57%
Insider Trans-Inst Trans-
Short Float0.81%EarningsMay 30
Analyst Recom1.00Target Price15.00
Avg Volume48.03K52W Range1.81 - 4.48
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
WKHS - Workhorse Group Inc - Stock Price Chart
TickerWKHS [NASD, RUT]
CompanyWorkhorse Group Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap35.27MEPS (ttm)-10.41
P/E-EPS this Y51.68%
Forward P/E-EPS next Y28.09%
PEG-EPS past 5Y4.17%
P/S2.77EPS next 5Y-
P/B0.46EPS Q/Q35.58%
Dividend-Sales Q/Q-20.91%
Insider Own-Inst Own-
Insider Trans0.00%Inst Trans0.01%
Short Float-EarningsMay 20/a
Analyst Recom3.40Target Price6.85
Avg Volume79.63K52W Range2.12 - 544.00
Workhorse Group, Inc. is a technology company, which provides sustainable solutions to the commercial transportation sector. It operates as an original equipment manufacturer, which designs and builds battery-electric vehicles including trucks and aircraft. The company was founded by Stephen S. Burns on February 20, 2007, and is headquartered in Sharonville, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Declet Brandon TorresDirectorMay 14 '24Option Exercise0.00157,7280269,710May 16 07:32 PM
SCLX - Scilex Holding Company - Stock Price Chart
TickerSCLX [NASD]
CompanyScilex Holding Company
CountryUSA
IndustryDrug Manufacturers - General
Market Cap331.58MEPS (ttm)-0.89
P/E-EPS this Y58.01%
Forward P/E-EPS next Y9.46%
PEG-EPS past 5Y-
P/S7.05EPS next 5Y-
P/B-EPS Q/Q-9.63%
Dividend-Sales Q/Q2.85%
Insider Own34.74%Inst Own15.96%
Insider Trans0.42%Inst Trans-8.47%
Short Float5.98%EarningsMay 29
Analyst Recom1.00Target Price7.25
Avg Volume1.03M52W Range0.73 - 8.03
Jun-14-24 01:41PM Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA ) in Lumbosacral Radicular Pain (Sciatica) (GlobeNewswire) +8.05%
Jun-13-24 09:00AM Scilex Holding Company to Present Poster on ELYXYB (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024 (GlobeNewswire)
Jun-11-24 07:20PM Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies (GlobeNewswire) +18.75% +8.27%
09:00AM Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA (GlobeNewswire)
Jun-10-24 11:49AM Scilex Holding Company Announces Stocking of GLOPERBA is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S. (GlobeNewswire)
Jun-06-24 02:56PM Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba which will be launched in the US in the week of June 10th 2024 (GlobeNewswire) +9.26%
May-30-24 01:19PM Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company (GlobeNewswire)
May-24-24 01:40PM Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index (GlobeNewswire)
09:00AM Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company (GlobeNewswire)
May-14-24 09:00AM Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex's intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba (GlobeNewswire)
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ji HenryExecutive ChairpersonJun 18 '24Option Exercise1.416,0008,460311,273Jun 18 09:26 PM
SHAH JAISIMSee RemarksJun 14 '24Option Exercise1.4133,33347,00033,333Jun 14 04:02 PM
SHAH JAISIMSee RemarksMay 17 '24Buy0.9256,93952,099155,882May 17 05:36 PM
Chun JayDirectorMay 17 '24Buy0.9057,50051,641102,500May 17 06:41 PM
Ji HenryExecutive ChairpersonMay 17 '24Buy0.8850,00043,98550,070May 17 06:42 PM
BCG - Binah Capital Group Inc. - Stock Price Chart
TickerBCG [NASD]
CompanyBinah Capital Group Inc.
CountryUSA
IndustryAsset Management
Market Cap76.82MEPS (ttm)-0.31
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.38EPS next 5Y-
P/B22.61EPS Q/Q-25.11%
Dividend-Sales Q/Q-
Insider Own63.30%Inst Own1.33%
Insider Trans0.00%Inst Trans-
Short Float1.14%Earnings-
Analyst Recom-Target Price-
Avg Volume393.98K52W Range2.70 - 16.61
Binah Capital Group, Inc. engages in the provision of wealth management services. The company was founded on June 27, 2022 and is headquartered in Albany, NY.
AVTE - Aerovate Therapeutics Inc - Stock Price Chart
TickerAVTE [NASD, RUT]
CompanyAerovate Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap40.64MEPS (ttm)-3.03
P/E-EPS this Y-2.29%
Forward P/E-EPS next Y40.44%
PEG-EPS past 5Y-114.14%
P/S-EPS next 5Y-
P/B0.43EPS Q/Q-25.12%
Dividend-Sales Q/Q-
Insider Own33.29%Inst Own64.74%
Insider Trans-2.65%Inst Trans4.19%
Short Float11.49%EarningsMay 13/a
Analyst Recom3.00Target Price2.25
Avg Volume607.81K52W Range1.50 - 32.42
Jun-18-24Downgrade Wells Fargo Overweight → Equal Weight $35 → $2
Jun-18-24Downgrade TD Cowen Buy → Hold
Jun-18-24Downgrade Evercore ISI Outperform → In-line $27 → $2
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Verwijs MarinusCHIEF TECHNICAL OFFICERJun 14 '24Option Exercise14.5910,600154,65410,600Jun 14 06:00 PM
Eldridge George ASEE REMARKSJun 14 '24Option Exercise2.1415,00032,10020,022Jun 14 06:00 PM
Eldridge George ASEE REMARKSJun 14 '24Sale25.0315,000375,4505,022Jun 14 06:00 PM
Verwijs MarinusCHIEF TECHNICAL OFFICERJun 14 '24Sale25.0010,600265,0000Jun 14 06:00 PM
Gillies HunterCHIEF MEDICAL OFFICERJun 13 '24Option Exercise2.146,00012,84011,602Jun 14 06:00 PM
SLRX - Salarius Pharmaceuticals Inc - Stock Price Chart
TickerSLRX [NASD]
CompanySalarius Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap-EPS (ttm)-173.74
P/E-EPS this Y-597.92%
Forward P/E-EPS next Y12.31%
PEG-EPS past 5Y64.97%
P/S-EPS next 5Y-
P/B0.06EPS Q/Q81.69%
Dividend-Sales Q/Q-
Insider Own6.08%Inst Own-
Insider Trans0.00%Inst Trans-3.23%
Short Float-EarningsMay 09
Analyst Recom3.00Target Price26.00
Avg Volume17.87K52W Range3.09 - 12.48
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
NNVC - NanoViricides Inc - Stock Price Chart
TickerNNVC [AMEX]
CompanyNanoViricides Inc
CountryUSA
IndustryBiotechnology
Market Cap19.37MEPS (ttm)-0.81
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.25%
P/S-EPS next 5Y-
P/B1.82EPS Q/Q-7.59%
Dividend-Sales Q/Q-
Insider Own4.60%Inst Own10.12%
Insider Trans0.00%Inst Trans19.10%
Short Float1.33%EarningsMay 14
Analyst Recom1.00Target Price6.50
Avg Volume219.29K52W Range1.00 - 3.59
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
EM - Smart Share Global Ltd ADR - Stock Price Chart
TickerEM [NASD]
CompanySmart Share Global Ltd ADR
CountryChina
IndustryPersonal Services
Market Cap210.14MEPS (ttm)0.04
P/E23.11EPS this Y162.57%
Forward P/E12.41EPS next Y24.45%
PEG-EPS past 5Y-
P/S0.59EPS next 5Y-
P/B0.66EPS Q/Q-103.28%
Dividend-Sales Q/Q-54.05%
Insider Own2.76%Inst Own1.94%
Insider Trans0.00%Inst Trans-0.34%
Short Float0.01%EarningsJun 03/b
Analyst Recom1.00Target Price1.74
Avg Volume330.73K52W Range0.41 - 1.17
Smart Share Global Ltd. operates as a consumer tech company providing mobile device charging service through an online and offline network. It provides service through its power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs and public spaces. The company was founded by Guang Yuan Cai, Pei Feng Xu, Yaoyu Zhang and Xiaowei Li in May 2017 and is headquartered in Shanghai, China.
1234567891020